Expression of the aging gene p66Shc is increased in peripheral blood monocytes of patients with acute coronary syndrome but not with stable coronary artery disease

Autor: Jan Steffel, Fabian C. Franzeck, Alexander Akhmedov, Giovanni G. Camici, Willibald Maier, Remo D. Spescha, Thomas F. Lüscher, Matthias Hasun, Felix C. Tanner, Christophe A. Wyss, Danielle Hof, Yi Shi, Arnold von Eckardstein, Francesco Cosentino
Přispěvatelé: University of Zurich, Camici, Giovanni G
Rok vydání: 2012
Předmět:
Male
medicine.medical_treatment
030204 cardiovascular system & hematology
Coronary Angiography
Monocytes
p66shc
10052 Institute of Physiology
Coronary artery disease
Pathogenesis
0302 clinical medicine
Malondialdehyde
540 Chemistry
oxidative stress
Myocardial infarction
10038 Institute of Clinical Chemistry
Whole blood
Cardiac catheterization
0303 health sciences
Reverse Transcriptase Polymerase Chain Reaction
acute coronary syndrome
coronary artery disease
Middle Aged
Up-Regulation
3. Good health
10076 Center for Integrative Human Physiology
Right coronary artery
10209 Clinic for Cardiology
Cardiology
Biomarker (medicine)
Cardiology and Cardiovascular Medicine
Switzerland
medicine.medical_specialty
Acute coronary syndrome
Src Homology 2 Domain-Containing
Transforming Protein 1

610 Medicine & health
Real-Time Polymerase Chain Reaction
2705 Cardiology and Cardiovascular Medicine
03 medical and health sciences
medicine.artery
Internal medicine
medicine
Humans
RNA
Messenger

030304 developmental biology
Chi-Square Distribution
business.industry
medicine.disease
Shc Signaling Adaptor Proteins
570 Life sciences
biology
Lipid Peroxidation
business
Zdroj: Atherosclerosis
DOI: 10.1016/j.atherosclerosis.2011.10.035
Popis: Objective The interplay between oxidative stress and inflammation is crucial in the pathogenesis of atherosclerosis. The adaptor protein p66Shc is implicated in atherogenesis and oxidative stress related responses in animal models of diseases. However, its role in humans remains to be defined. In this study, we hypothesized that expression of p66Shc increases in peripheral blood monocytes of patients affected by acute coronary syndromes (ACS). Methods Male subjects aged 59 ± 4 (mean ± SD) years admitted for cardiac catheterization were subdivided in three groups: (a) no local stenosis for the control group, (b) at least one stenosis ≥75% in either left, circumflex or right coronary artery for the coronary artery disease (CAD) group or (c) ST-elevation/non-ST-elevation myocardial infarction for the ACS group. Monocytes were isolated from whole blood and p66Shc RNA levels were determined by quantitative real time PCR. Results p66Shc RNA levels were increased in ACS patients as compared to CAD (p = 0.007) and controls (p = 0.0249). Furthermore, malondialdehyde (MDA) and C-reactive protein (CRP) were increased in plasma of ACS patients. Levels of MDA correlated positively to p66Shc (r = 0.376, p = 0.01). Our data demonstrate increased p66Shc levels in monocytes of ACS but not CAD patients. Conclusion This study suggests an involvement of p66Shc in the transition of a stable CAD to an ACS patient. p66Shc was associated with states of increased oxidative stress. Further work is needed to understand whether p66Shc may represent a possible pharmacological target or whether it represents an interesting novel biomarker.
Databáze: OpenAIRE